COV vs ENP

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

47LOW

ENP

ENTRONEURO FPO [ENP]

47LOW

Score Breakdown

COV ENP
Technical
67
49
Catalyst
55
51
Sentiment
50
50
Fundamental
65
59
Momentum
76
37
Risk Gate
46
45

Key Metrics

COV Metric ENP
$65.0MMarket Cap$45.3M
193KAvg Volume (20d)1.6M
N/AShort InterestN/A
$0.90052-Week High$0.038
$0.31052-Week Low$0.028
+19.4%Daily Change-3.4%
$0.555Entry Price$0.028
-49.6%ROEN/A
-157.4%Profit Margin-299.6%

Active Signals

COV Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 18.1% over the last 5 days
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (15 quarters)
●4C filed 2026-01-28
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

ENP Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 12.5% over the last 5 days
●Adequate cash runway (5 quarters)

Ask Scout AI to compare COV and ENP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
COV Full Analysis → ENP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).